Tether bids $200 million on BlackRock Neurotech

Tether has invested $200 million in BlackRock Neurotech, confirming its position as a majority shareholder.

This strategic investment by Tether marks a significant shift into Brain-Computer-Interface (BCI) technology, underscoring the company's vision to improve human potential through technology.

Tether Expands Portfolio With BlackRock Neurotech Investment

BlackRock Neurotech is at the forefront of BCI development. Based in Salt Lake City, Utah, the company develops cutting-edge technologies that help individuals with severe neurological conditions. The devices allow users to perform complex tasks such as controlling robotic arms, driving wheelchairs, and driving cars.

The investment from Tether will primarily support BlackRock's medical solutions business and broader rollout. Additionally, it will strengthen ongoing research and development efforts to maintain BlackRock Neurotech's leadership in the BCI space.

Tether CEO Paolo Arduino described the investment as a step forward. It aims to deeply integrate human cognitive capabilities with transformative technologies that connect advanced computing.

“BlackRock Neurotech is the beginning of our journey with Tether Evo to engage in projects that push the boundaries of what can be done at the intersection of technological innovation and human potential,” said Arduino.

Florian Solzbacher, founder of BlackRock Neurotech, highlighted the potential for the integration of health care and technology to increase dramatically.

Read more: 9 Best Crypto Wallets to Store Tether (USDT)

This strategic partnership reflects Tether's diversification from its Starga coin roots and aligns with its broader vision to harness the power of technology across multiple sectors.